2022 Speaker Faculty

Meet the expert speakers uniting in Boston this June to provide you with the know-how to harness the power of TCRs 

Adrian Rawcliffe

CEO

Adaptimmune

Cintia Piccina

Chief Commercial Officer

Adaptimmune

Joanna Brewer

Chief Scientific Officer

Adaptimmune

Piotr Pierog

VP, Precision & Translational Medicine

Affini-T Therapeutics

Reagan Jarvis

CEO

Anocca

Tom Soloway

CEO

T-knife Thearpeutics

Dongxing Zha

CTO, TCR Discovery & Engineering

Alloy Therapeutics

Gang Zeng

President & CEO

T-Cure Bioscience Inc.

Sungeun Kim

Principal Scientist, Oncology Research

Amgen

Cheng Liu

Founder & CEO

Eureka Therapeutics

Katja Fink

Senior Director, Discovery

ImmunoScape

Stefania Gobessi

Director, Discovery

Gadeta

Franco Marincola

SVP, Global Head of Research

Kite Pharma

Parameswaran Hari

SVP, Clinical Science

Iovance Biotherapeutics

Stephen Megit

VP, Business Development

Immunocore

Aaron Vernon

VP, Manufacturing

TCR2 Therapeutics

Shannon Oda

Assistant Professor

Seattle Children’s Research Institute & University of Washington

Thomas Andresen

CEO

T-Cypher Bio

Cagan Gurer

VP, Discovery

TScan Therapeutics

Peggy Sotiropoulou

CSO

T-knife Therapeutics

Sadhak Sengupta

Associate Director, Immunology

Triumvira Immunologics

James Clements

Senior Director, Cell Therapy Immunology

Athenex

Michael Sheldon

Senior Director, Scientific Affairs

Sampled

Thomas Holberg Blicher

Senior Research Scientist

Immudex

Eduardo Davila

Professor, Dept of Medicine

University of Colorado Comprehensive Cancer Center

Jens Eberlein

Technical Lead, Immuno-Oncology

LUMICKS

Marvin Gee

VP, Target Discovery & Co-Founder, 3T Biosciences

3T Biosciences

VIEW WORKSHOPS
VIEW AGENDA
BACK TO TOP